Jack Kain is director and medical science liaison of Drug Monitoring and Toxicology at Quest Diagnostics. He has served as a consultant, clinical toxicologist and medical science liaison for multiple toxicology laboratories.


CDC’s Proposed Opioid Prescribing Guideline: Does it Fall Short on Drug Testing?

April 18, 2022

Last month, the Centers for Disease Control and Prevention shared a draft update to its Clinical Practice Guideline for Prescribing Opioids. The proposed revision comes as the nation’s overdose death rate reaches an all-time high, fueled largely by the economic and psychological strains and lack of healthcare access caused by COVID-19.